Related Experiment Video
Updated: Nov 7, 2025
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
70.1K
Carbohydrate Intake Prior to Oral Glucose Tolerance Testing
Klara R Klein1, Christopher P Walker2,3, Amber L McFerren2,3
1Division of Endocrinology and Metabolism, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.
Journal of the Endocrine Society
|April 30, 2021
Summary
Inadequate carbohydrate intake before an oral glucose tolerance test (OGTT) can falsely elevate results, mimicking diabetes. Proper patient preparation, including sufficient dietary carbohydrates, is crucial for accurate OGTT interpretation.
Area of Science:
- Endocrinology
- Metabolic Research
- Clinical Diagnostics
Background:
- Oral glucose tolerance tests (OGTTs) are infrequently used in modern endocrinology practice, partly due to the rise of glycated hemoglobin testing.
- Consequently, established protocols for patient preparation, particularly regarding carbohydrate intake, have become less emphasized.
- Historical literature highlights the critical role of adequate carbohydrate consumption before an OGTT.
Purpose of the Study:
- To investigate the impact of insufficient carbohydrate intake on OGTT results.
- To illustrate how poor preparation can lead to misinterpretation of glucose metabolism.
- To emphasize the need to revisit and adhere to established OGTT preparation guidelines.
Main Methods:
- A case study of an OGTT performed in a research setting with inadequate pre-test carbohydrate intake.
- Comparison of OGTT results before and after correction of dietary preparation.
- Physiological exploration of the mechanisms underlying the observed glucose responses.
Main Results:
- An OGTT conducted after insufficient carbohydrate intake showed elevated plasma glucose levels at 1 and 2 hours.
- These results mimicked the impaired insulin release characteristic of early type 1 and type 2 diabetes.
- A repeat OGTT following adequate carbohydrate intake (>150g/day, >50g evening prior) yielded normal results.
Conclusions:
- Insufficient carbohydrate intake prior to an OGTT can significantly compromise test accuracy.
- This can lead to misdiagnosis and unnecessary patient anxiety and further testing.
- Re-emphasizing and adhering to historical patient preparation guidelines is essential for reliable OGTT outcomes in clinical and research settings.
More Related Videos
Related Concept Videos
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
349
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
349
01:15Hypoglycemia and Glucagon
506
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
506
01:06Oral Hypoglycemic Agents: Glinides
354
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
354
01:02Glucose Homeostasis: Regulation of Blood Glucose
3.0K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.0K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
400
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
400
01:19Overview of Carbohydrate Metabolism
2.4K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.4K